# Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024
> **Notice** · Notice with request for comments. · Published 2024-09-25 · 89 FR 78764
## Document
- **Document number:** 2024-21960
- **Category:** quota
- **Type:** Notice
- **Action:** Notice with request for comments.
- **Citation:** 89 FR 78764
- **Publication date:** 2024-09-25
## Abstract

The Drug Enforcement Administration proposes to adjust the 2024 aggregate production quotas for several controlled substances in schedules I and II of the Controlled Substances Act. Additionally, as DEA announced in an April 29, 2024 letter to DEA-registered manufacturers, procurement quotas for commercial manufacturing of a schedule II controlled substance will be calculated on a semi-annual basis, except for injectable drug products containing schedule II controlled substances, which will be calculated on an annual basis.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2024/09/25/2024-21960/proposed-adjustments-to-the-aggregate-production-quotas-for-schedule-i-and-ii-controlled-substances)
---
*AI Analytics · CC0 1.0*